R&D News | pharmaphorum

News

Shanghai/China-Jan.2020: New type coronavirus pneumonia in Wuhan has been spreading many cities in China. People wearing surgical mask sitting in subway in Shanghai

GSK donates booster technology to coronavirus vaccine effort

GlaxoSmithKline has joined with the not-for-profit organisation the Coalition for Epidemic Preparedness Innovations (CEPI) to supply a booster for a potential Wuhan coronavirus vaccine.

News

Blood sample with respiratory coronavirus positive

WHO declares coronavirus 'emergency' as cases confirmed in U...

The World Health Organization has declared that the new strain of coronavirus is a global emergency, as cases mount outside China.

News

Closeup of X-ray photography of human brain

Alector launches $208m fundraiser for Alzheimer's R&D with A...

Alector has launched an $208 million stock market offering as it ramps up clinical trials with AbbVie into a drug that aims to tackle Alzheimer’s by modifying the brain’s immune system.

News

Incyte gets much-needed boost as eczema cream trial hits tar...

US biotech Incyte has announced positive topline results from a phase 3 trial of its ruxolitinib eczema cream in adults and adolescents aged 12 or above, sending its shares ticking up.

News

GSK licenses TB vaccine to Bill and Melinda Gates Institute

GlaxoSmithKline has licensed its potential tuberculosis vaccine to the Bill and Melinda Gates Medical Research Institute, saying this is the best way for it to be developed for low-income c

News

Quench targets lupus and rare diseases with R&D into new dru...

Quench Bio has emerged from stealth mode with $50 million of committed funding, bidding to be the first company to target Gasdermin D (GSDMD) in inflammatory disease indications poorly serv

GSK donates booster technology to coronavirus vaccine effort

WHO declares coronavirus 'emergency' as cases confirmed in U...

Alector launches $208m fundraiser for Alzheimer's R&D with A...

Incyte gets much-needed boost as eczema cream trial hits tar...

GSK licenses TB vaccine to Bill and Melinda Gates Institute

Quench targets lupus and rare diseases with R&D into new dru...

Bayer plans filings for cardiac amyloidosis imaging agent

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks